Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome
Clinical trial NCT05391789 · UNKNOWN
Trial details
- NCT number
- NCT05391789
- Sponsor
- Huashan Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.